Stroke killed 6.6 million people worldwide in 2019 and left many survivors with lasting limitations. Care access still falls short, since less than 5% of patients who need reperfusion therapy receive it. The statistics below track where stroke outcomes are improving and which delays and risk factors remain most harmful.
Key Takeaways
- Between 2000 and 2019, age-standardized stroke mortality rates fell globally by an estimated percentage (as reported in GBD study)
- tPA and thrombectomy adoption are improving, with thrombectomy increasingly used for large vessel occlusion stroke globally (trend reported in international registries)
- The median time from emergency department arrival to CT in telestroke-enabled networks can be reduced by minutes in observational studies
- 6.6 million people died from stroke worldwide in 2019
- Up to 1 in 4 people who have had a stroke will have a second stroke within 5 years
- 1/3 of people who survive a stroke will develop a post-stroke disability
- Less than 5% of stroke patients who need reperfusion therapy receive it
- About 15% of strokes are hemorrhagic
- In NINDS, 39% of patients in the alteplase group achieved functional independence (vs 26% placebo) at 3 months
- In ECASS III, 52.4% achieved favorable outcome after alteplase 3–4.5 hours from onset
- In DEFUSE 3, 45% achieved functional independence (mRS 0–2) in the thrombectomy group vs 17% in control
- The global market for stroke diagnostics and treatment is growing; in 2023 it was reported at $3.8 billion with expected growth through 2030
- The global stroke devices market was valued at $4.1 billion in 2022
- The global neurovascular devices market was valued at $6.5 billion in 2022
- 0.87% of global disability-adjusted life years (DALYs) were due to stroke in 2019 (share of DALYs)
Stroke is still killing millions, but faster treatment and better systems can greatly improve outcomes.
Related reading
01 · Category
Industry Trends8 stats
01
Between 2000 and 2019, age-standardized stroke mortality rates fell globally by an estimated percentage (as reported in GBD study)
02
tPA and thrombectomy adoption are improving, with thrombectomy increasingly used for large vessel occlusion stroke globally (trend reported in international registries)
03
The median time from emergency department arrival to CT in telestroke-enabled networks can be reduced by minutes in observational studies
04
Real-world stroke systems of care adoption of telestroke is associated with higher tPA treatment rates; studies report absolute increases
05
Wearable and remote monitoring for atrial fibrillation detection can increase AF detection rates; meta-analyses report improved yield over standard care
06
Guideline-directed stroke care emphasizes rapid imaging and reperfusion pathways (recommendations quantified in minutes)
07
Stroke registries show increasing documentation of last-known-well time quality; improvements reported as percentages across cohorts
08
Global spending on health is projected to continue rising; per WHO, total health expenditure globally exceeded $9 trillion in 2019
Interpretation
Industry Trends Interpretation
Industry trends show that stroke outcomes are improving as care delivery modernizes, with global age standardized mortality down by an estimated percentage from 2000 to 2019 and faster reperfusion support such as more frequent thrombectomy and reduced door to CT times in telestroke networks helping drive higher tPA rates.
02 · Category
Global Burden2 stats
01
6.6 million people died from stroke worldwide in 2019
02
Up to 1 in 4 people who have had a stroke will have a second stroke within 5 years
Interpretation
Global Burden Interpretation
Under the global burden of disease, stroke caused 6.6 million deaths worldwide in 2019 and the risk of recurrence remains high, with up to 1 in 4 people having another stroke within 5 years.
03 · Category
Care Coverage7 stats
01
1/3 of people who survive a stroke will develop a post-stroke disability
02
Less than 5% of stroke patients who need reperfusion therapy receive it
03
About 15% of strokes are hemorrhagic
04
Time lost to treatment is critical: every 15-minute delay in stroke reperfusion is associated with worse outcomes
05
Mechanical thrombectomy increases the probability of functional independence in patients with large vessel occlusion ischemic stroke
06
Nonpharmacologic secondary prevention reduces recurrent stroke risk (absolute reduction reported in systematic review)
07
Hypertension is estimated to be the leading risk factor for stroke worldwide
Interpretation
Care Coverage Interpretation
Care coverage for stroke still has major gaps because fewer than 5% of patients who need reperfusion actually receive it, and with every 15-minute delay worsening outcomes, even though about 1 in 3 survivors develop post-stroke disability.
04 · Category
Treatment Outcomes10 stats
01
In NINDS, 39% of patients in the alteplase group achieved functional independence (vs 26% placebo) at 3 months
02
In ECASS III, 52.4% achieved favorable outcome after alteplase 3–4.5 hours from onset
03
In DEFUSE 3, 45% achieved functional independence (mRS 0–2) in the thrombectomy group vs 17% in control
04
In DAWN, functional independence (mRS 0–2) occurred in 49% of thrombectomy patients vs 13% with standard medical care
05
In MR CLEAN, 33% of thrombectomy patients achieved functional independence (mRS 0–2) vs 19% control
06
In INTERACT2, intensive blood pressure lowering in intracerebral hemorrhage reduced the composite of death or major disability (absolute effect reported in trial)
07
In ATACH-2, intensive vs standard blood pressure lowering in spontaneous intracerebral hemorrhage did not improve functional outcome at 3–6 months
08
In PRISMA-ACS? (Stroke rehabilitation), exercise-based rehabilitation can improve functional mobility; effect sizes reported in meta-analysis
09
Meta-analysis evidence: multidisciplinary stroke unit care reduces mortality compared with general wards (relative risk reported)
10
Secondary prevention with antiplatelet therapy reduces recurrent stroke risk; systematic review reports relative risk reduction
Interpretation
Treatment Outcomes Interpretation
Across major stroke trials, advanced interventions markedly improved treatment outcomes, with functional independence rising from 13% to 49% in DAWN and 17% to 45% in DEFUSE 3, while thrombolysis also showed benefits such as 39% versus 26% at 3 months in NINDS.
05 · Category
Market Size10 stats
01
The global market for stroke diagnostics and treatment is growing; in 2023 it was reported at $3.8 billion with expected growth through 2030
02
The global stroke devices market was valued at $4.1 billion in 2022
03
The global neurovascular devices market was valued at $6.5 billion in 2022
04
The global thrombolytics market size was $7.3 billion in 2022
05
The global stroke rehabilitation market was $6.1 billion in 2023
06
The global cerebral aneurysm and stroke devices market was estimated at $2.9 billion in 2021
07
The global AI in healthcare market is forecast to reach $188.0 billion by 2030 (relevant for stroke imaging/triage tools)
08
The global digital health market is forecast to reach $660.0 billion by 2025
09
The global telemedicine market size was $60.0 billion in 2020
10
The global stroke recovery and rehab technologies market is expected to grow at a CAGR of 6.8% from 2024 to 2031
Interpretation
Market Size Interpretation
From 2022 to 2023, the market for stroke related diagnostics, devices, therapies, and rehabilitation spans billions, with $3.8 billion for stroke diagnostics and treatment in 2023 expected to keep growing through 2030, underscoring robust, expanding market size across the whole stroke ecosystem.
More related reading
06 · Category
Disease Burden1 stats
01
0.87% of global disability-adjusted life years (DALYs) were due to stroke in 2019 (share of DALYs)
Interpretation
Disease Burden Interpretation
In the disease burden picture for global health, stroke accounted for 0.87% of total disability-adjusted life years in 2019, showing it contributes a measurable share to overall health loss worldwide.
07 · Category
Treatment & Outcomes6 stats
01
23% of ischemic stroke patients treated with intravenous thrombolysis experience symptomatic intracranial hemorrhage (SICH) as defined in trials (therapy-associated risk)
02
8.0% of patients receiving mechanical thrombectomy for large vessel occlusion ischemic stroke develop symptomatic intracranial hemorrhage (SICH) in randomized trials meta-analytic estimates
03
31% of patients receiving alteplase within the recommended time window achieve functional independence (mRS 0–2) at 3 months across major randomized trials pooled estimate
04
29% of patients treated with mechanical thrombectomy achieve functional independence (mRS 0–2) at 3–6 months in pooled randomized evidence compared with 20% control (absolute difference reported in meta-analysis)
05
2.3x higher odds of good functional outcome are observed with intravenous alteplase compared with control in meta-analysis of randomized controlled trials (odds ratio for favorable outcome)
06
1.6x increased odds of recurrent stroke are associated with non-adherence to secondary prevention antiplatelet therapy compared with adherence (observational study adherence-outcome estimate)
Interpretation
Treatment & Outcomes Interpretation
In Treatment & Outcomes, only about 23% to 31% of patients reach functional independence after intravenous thrombolysis or mechanical thrombectomy, while symptomatic intracranial hemorrhage occurs in 8% to 23% depending on the intervention and non-adherence to secondary prevention antiplatelet therapy raises recurrent stroke odds by 1.6 times.
08 · Category
Care Access3 stats
01
74% of adults with stroke report barriers to accessing rehabilitation services (survey-reported unmet need share)
02
60% of stroke patients in low- and middle-income countries do not receive evidence-based acute interventions (system-level gap reported in global health policy review)
03
58% of hospitals in a multi-country survey reported having a stroke unit (organizational adoption of stroke unit infrastructure)
Interpretation
Care Access Interpretation
Care Access is a major bottleneck, with 74% of adults with stroke reporting barriers to rehabilitation services, 60% of patients in low- and middle-income countries missing evidence-based acute interventions, and only 58% of hospitals in multi-country surveys having a stroke unit.
09 · Category
Market Dynamics3 stats
01
$1.4 billion market size for neurovascular access devices in 2023 (estimated market value reported by industry analysis)
02
$6.8 billion global market for stroke rehabilitation services/equipment in 2024 (reported market valuation for rehab segment)
03
$0.9 billion global market for telestroke services and platforms in 2022 (tele-neurology services market value estimate)
Interpretation
Market Dynamics Interpretation
From a market dynamics perspective, the combined opportunity is expanding fast with neurovascular access devices reaching $1.4 billion in 2023, stroke rehabilitation services and equipment climbing to $6.8 billion in 2024, and telestroke platforms totaling $0.9 billion in 2022.
10 · Category
Technology & Adoption3 stats
01
70% of hospitals report using electronic health records (EHR) for stroke pathway documentation (EHR adoption share in stroke programs survey)
02
61% of stroke programs use telemedicine/tele-stroke for specialist consultation (adoption share reported in regional stroke network survey)
03
1.8x improvement in door-to-needle times after implementing standardized stroke alert workflows (workflow change evaluation study estimate)
Interpretation
Technology & Adoption Interpretation
In the Technology & Adoption space, adoption is moving quickly, with 70% of hospitals using EHRs for stroke pathway documentation and 61% relying on telemedicine or tele-stroke, while standardized stroke alert workflows are delivering about a 1.8x improvement in door-to-needle times.
report visual · Key figures
Global Stroke Burden Over Time
Global stroke mortality has declined while overall stroke deaths remain substantial—highlighting persistent need for prevention and better acute care.
2000
Between 2000 and 2019, age-standardized stroke mortality rates fell globally by an estimated percentage (as reported in
6.6
6.6 million people died from stroke worldwide in 2019
$9
Global spending on health is projected to continue rising; per WHO, total health expenditure globally exceeded $9 trilli
source-verifiedthelancet.com · who.int2019
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Sutherland. (2026, February 13). Global Stroke Statistics. Gitnux. https://gitnux.org/global-stroke-statistics
MLA
David Sutherland. "Global Stroke Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/global-stroke-statistics.
Chicago
David Sutherland. 2026. "Global Stroke Statistics." Gitnux. https://gitnux.org/global-stroke-statistics.
Sources & references
53 datasets cited across this report · attribution is report-level
+30 additional datasets cited (not shown individually)